Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

7237b9215dffd081d54d788.dqYKfI3er8zCN4unfWoOn8Ep2FcMiMWswmW0VfXwNlM.GpYyKMGRyriEUcbPNT1q-Y9_liZa5f3CiwvcFJG3eREu83sGz6zMracF5A~2b9a4e3222f90e6a0d5b8149906b2a2e
07-31 Stride Shares Fall After William Blair Downgrade MT
07-31 William Blair Downgrades Stride to Market Perform From Outperform MT
25-10-29 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
25-10-29 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
25-10-06 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
25-08-29 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
25-08-06 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
25-08-05 Stride Q4 revenue, adjusted EPS beat estimates RE
25-04-30 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
25-04-30 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
25-04-21 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
25-04-21 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
25-01-29 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
24-10-23 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
24-08-20 Stride Shares Fall After Citigroup Downgrade MT
24-08-20 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
24-08-08 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
24-08-08 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
24-07-31 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24-04-24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
24-01-25 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
24-01-25 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
24-01-24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
23-11-16 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
23-11-16 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.76%
+39.52%
+37.4%
+9.55%
+20.82%
+35.23%
+16.26%
- - +37.46%
+37.12%
+19.44%
Average +28.36%
Weighted average by Cap. +29.09%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
83.43USD
Average target price
109.00USD
Spread / Average Target
+30.65%
High Price Target
125.00USD
Spread / Highest target
+49.83%
Low Price Target
93.00USD
Spread / Lowest Target
+11.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

William Blair & Co.
BMO Capital
Morgan Stanley
Barrington Research
Citigroup
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
83.43USD
Average target price
109.00USD
Spread / Average Target
+30.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LRN Stock
  4. Consensus Stride, Inc.